Global Stem cell Technology (GST) NV is a veterinary biotech company which was founded in 2012 to develop and produce state-of-the art stem cell products for horses and dogs. The research and development department of the company performs scientifically superior studies in order to create robust, reproducible and reliable products. The production and quality department are responsible for the validation of the new products and techniques and for high-scale production of these advanced stem cell products under GMP circumstances.
Subsequently, the clinical trials unit investigates the safety and efficacy of these products from clinical phase I up to clinical phase III. GST thus translates regenerative medicine into evidence-based clinical applications. Thanks to the highly efficient interdepartmental collaboration, the company is known for robust and reliable product development where integrity, high quality services, and animal welfare are solid company values. The young driven, divers and dynamic team and the horizontal hierarchical structure assemble the foundation of the friendly and familiar atmosphere present.